| TER |
Report |
Q2 Revenue |
BEAT |
pred ~$1.235B vs. cons $1.216B |
MEDIUM |
| TER |
Report |
Q2 Non-GAAP Diluted EPS |
BEAT |
pred ~$2.09 vs. cons $2.05 |
MEDIUM |
| TER |
Report |
Q2 Semiconductor Test Revenue |
BEAT |
pred ~$1.070B vs. cons $1.042B |
MEDIUM |
| TER |
Guide |
Q3 Revenue |
LOWER |
guide ~$1.00B vs. cons $1.033B |
MEDIUM |
| TER |
Guide |
Q3 Non-GAAP Diluted EPS |
LOWER |
guide ~$1.40 vs. cons $1.46 |
MEDIUM |
| TER |
Guide |
H2 2026 demand / visibility |
LOWER |
guide: continued AI demand but limited H2 visibility vs. cons UNVERIFIED |
LOW |
| TER |
Return |
Day-1 residual (stock − beta × S&P 500) |
-6.0% |
— |
MEDIUM |
| TER |
Return |
5-day cumulative residual |
-4.0% (FADE) |
FADE — Q3 estimate cuts outweigh Q2 beat, but valuation reset limits follow-through |
MEDIUM |